EM
Ejner Moltzen
Innovation Fund Denmark, Denmark
Presentation
Ejner Moltzen is a medicinal chemist by training and has for over almost 30 years been working within R&D at H. Lundbeck A/S in different managerial as well as strategic positions. He has been heavily involved with running efficient drug discovery projects, both in terms of delivering candidates for clinical trials and in terms of optimizing the related processes. He was part of Lundbeck’s global research management and thereby involved with setting the company’s research strategies and activities. He was also responsible for alliance management within R&D and was involved with both company collaborations as well as public-private partnerships, where he represented Lundbeck in EFPIA/IMI context. In 2016 he became independent and founded Somami Consulting ApS, which is a consulting company focusing on providing support within R&D projects, operations, alliance management, strategy and policy initiatives, collaboration contracts and project evaluations. He is supporting public agencies as well as private enterprises, nationally as well as internationally. He is in particular involved with Innovation Fund Denmark where he is this agency’s lead representative within international activities relating to personalized medicine. He is currently elected as Chair of ICPermed which is an EC funded European initiative to promote implementation of personalized medicine.
Loading